Clinical Trials · NCT00993356
Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Enrollment
- 96
- Start date
- Jan 2004
- Locations
- 1 site, China
- Primary endpoint
- Cure rate at evaluation 4 months postoperatively